Erasca, Inc. announced the termination of its Chief Operating Officer, Dr. Nicholas Chetwyn, effective November 2, 2026, citing leadership realignment for its RAS-targeting programs. Following this announcement, Erasca's stock price dropped nearly 10%, falling $1.48 to $13.39 per share. Pomerantz LLP has launched an investigation into whether Erasca and its executives engaged in securities fraud or other unlawful practices. Investors affected by this development are encouraged to contact Pomerantz LLP for potential class action participation.
Erasca Inc. shares trade at USD 15.18 on Pluang as of Oct 29, 2026, 21:02 WIB, up 0.40% in one day. The stock's market cap stands at $5.30 billion with a trading volume of 3,391,417 shares. Despite recent news, the stock remains well above its 52-week low of $2.20.
Grabar Law Office is investigating claims against officers and directors of Erasca, Planet Fitness, PROCEPT BioRobotics, and The Simply Good Foods Company for alleged breaches of fiduciary duties. The investigations focus on misleading statements and...
Pomerantz LLP is investigating Erasca, Inc. following the announced termination of COO Nicholas Chetwyn, which led to a nearly 10% drop in the company's stock price. The investigation focuses on whether Erasca and its officers engaged in securities f...
